Willow Biosciences Inc T.WLLW

Alternate Symbol(s): CANSF

Willow Biosciences Inc. is a Canada-based biotechnology company. The Company develops and produces precision fermented functional ingredients for the health and wellness, food and beverage and personal care markets. Its FutureGrown biotechnology platform allows production with sustainability at its core. Its commercial product, Cannabigerol CBG, which is a cannabinoid that has anti-microbial, anti-inflammatory, and antioxidant properties. It also offers BioOxi, a bio-oxidation technology platform. By leveraging BioOxi, commercial partners can revolutionize manufacturing of oxygenated and hydroxylated functional ingredients, such as steroids, polyphenols, oxyterpenes and certain other targeted ingredients produced from such methods. It is also developing BioOxi-based process for production of the generic active pharmaceutical ingredient (API), hydrocortisone, and its derivatives. Its other pipeline products include Ursodeoxycholic acid (UCAC), Astaxanthin, B-carotene and others.

TSX:WLLW - Post by User

Willow Biosciences Inc

Bullboard Posts

Post by 1option1on Oct 04, 2015 12:48am

138 Views

Post# 24161063

Drill Permit Approved by Saskatchewan for Patterson Uranium

Drill Permit Approved by Saskatchewan for Patterson Uranium Drilling

Vancouver, BC / TheNewswire / October 2 2015 - Makena Resources Inc. (the "Company" or "Makena") (TSX-V: MKN) is pleased to announce that the drill permit for the Patterson Uranium Prospect has been approved by the Saskatchewan government. Negar Adam, President of Makena states, "This is a very positive step forward. We anticipate the drill program to commence shortly. The Athabasca Basin is in one of the foremost Uranium…Read More

Bullboard Posts

What will the U.S. election results mean for Canada?